Bridged tricyclic carbamoylpyridone compounds and uses thereof
US12024528B2 · kind B2 · utility
6Cited by
9References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 14, 2023 |
| Grant date | Jul 2, 2024 |
| Priority date | — |
| Expiry date | Jun 14, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates generally to compounds, of Formula I:Also disclosed are pharmaceutical compositions comprising said compounds and methods of making said compounds. The compounds of the disclosure are useful in treating or preventing human immunodeficiency virus (HIV) infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.